ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673793 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673793; 2) Community: the network communities that were significantly associated with the response to NSC 673793; 3) Molecule: the relationships between components within communities and NSC 673793; 4) MDR: the compounds that were significantly associated with the NSC 673793.

NSC Compound Enrichment Correlation
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.000316293616993019 0.53808099
NSC 702759 Null 0.000316293616993019 -0.17068378
NSC 10848 Null 0.000332787192635313 -0.082478799
NSC 706995 Entinostat 0.000332787192635313 0.29919428
NSC 762557 Null 0.000380874609232495 -0.1803168
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.000380874609232497 -0.21967386
NSC 680553 2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester 0.000395532514722381 -0.36461416
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.000483960412931737 0.16185352
NSC 722995 Null 0.000483960412931737 0.14440388
NSC 293046 Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide 0.00057400073542549 0.34281493
Total:103  Current:3    [First] [Prev] [Next] [Last]